NYSE:XYL Xylem - XYL Earnings Date, Estimates & Call Transcripts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Xylem Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $98.59 +1.36 (+1.40%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$95.74▼$98.7950-Day Range$94.73▼$116.9352-Week Range$72.08▼$118.58Volume1.50 million shsAverage Volume1.59 million shsMarket Capitalization$17.77 billionP/E Ratio50.30Dividend Yield1.34%Price Target$114.80 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Earnings Summary Upcoming Earnings DateMay. 4ConfirmedActual EPS (Feb. 7) $0.92 Beat By $0.13 Consensus EPS (Feb. 7) $0.79 Last Year's Q1 EPS (2/3/2022) $0.63Read Call TranscriptListen to CallSkip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueXYL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.XYL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.Xylem Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20232$0.61$0.63$0.62 Q2 20232$0.79$0.80$0.80 Q3 20232$0.82$0.84$0.83 Q4 20232$0.95$0.95$0.95 FY 20238$3.17$3.22$3.20 Q1 20241$0.67$0.67$0.67 Q2 20241$0.85$0.85$0.85 Q3 20241$1.02$1.02$1.02 Get Xylem Earnings AlertsEnter your email address below to receive the latest news and earnings results for XYL and its competitors with MarketBeat's FREE daily newsletter. XYL Earnings Date and InformationXylem last issued its earnings results on February 7th, 2023. The industrial products company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.79 by $0.13. The business had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.41 billion. Its revenue for the quarter was up 13.8% compared to the same quarter last year. Xylem has generated $1.96 earnings per share over the last year ($1.96 diluted earnings per share) and currently has a price-to-earnings ratio of 50.3. Earnings for Xylem are expected to grow by 11.56% in the coming year, from $3.20 to $3.57 per share. Xylem has confirmed that its next quarterly earnings report will be published on Thursday, May 4th, 2023. Xylem will be holding an earnings conference call on Thursday, May 4th at 9:00 AM Eastern. Interested parties can register for or listen to the call. or dial in at 402-220-5384. Read More Xylem Earnings History by Quarter Export to ExcelDateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/4/2023(Confirmed) $0.62 2/7/2023Q4 22$0.79$0.92+$0.13$1.02$1.41 billion$1.51 billion 11/1/2022Q3 2022$0.66$0.79+$0.13$1.51$1.33 billion$1.38 billion8/2/2022Q2 2022$0.55$0.66+$0.11$0.70$1.33 billion$1.36 billion 5/4/2022Q1 2022$0.42$0.47+$0.05$0.49$1.24 billion$1.27 billion 2/3/2022Q4 2021$0.62$0.63+$0.01$0.64$1.31 billion$1.32 billion 11/2/20219/30/2021$0.59$0.63+$0.04$0.63$1.28 billion$1.27 billion 8/3/20216/30/2021$0.63$0.66+$0.03$0.70$1.32 billion$1.35 billion 5/4/20213/31/2021$0.37$0.56+$0.19$0.64$1.17 billion$1.26 billion 2/4/202112/31/2020$0.68$0.81+$0.13$0.80$1.29 billion$1.37 billion 10/29/20209/30/2020$0.52$0.62+$0.10$1.04$1.16 billion$1.22 billion 7/30/20206/30/2020$0.39$0.40+$0.01$0.63$1.15 billion$1.16 billion 5/5/20203/31/2020$0.37$0.23($0.14)$0.25$1.15 billion$1.12 billion 2/6/2020Q4 2019$0.89$0.89$1.13$1.38 billion$1.37 billion 10/31/20199/30/2019$0.82$0.82$1.28$1.33 billion$1.30 billion 8/1/20196/30/2019$0.79$0.79$0.81$1.35 billion$1.35 billion 5/2/20193/31/2019$0.58$0.52($0.06)$0.61$1.25 billion$1.24 billion 1/31/201912/31/2018$0.88$0.88$0.52$1.36 billion$1.39 billion10/30/20189/30/2018$0.77$0.77$0.82$1.30 billion$1.29 billion 7/31/2018Q2 2018$0.71$0.73+$0.02$0.82$1.28 billion$1.32 billion 5/1/2018Q1 2018$0.51$0.51$0.59$1.19 billion$1.22 billion 2/1/2018Q4 2017$0.76$0.76$1.12$1.27 billion$1.28 billion10/31/2017Q3 2017$0.64$0.65+$0.01$0.72$1.18 billion$1.20 billion8/1/2017Q2 2017$0.57$0.59+$0.02$0.63$1.17 billion$1.16 billion 5/2/2017Q1 2017$0.38$0.39+$0.01$0.39$1.05 billion$1.07 billion 2/2/2017Q4 2016$0.65$0.66+$0.01$1.04$1.13 billion$1.10 billion 11/1/2016Q3 2016$0.53$0.54+$0.01$0.67$913.53 million$897.00 million 8/2/2016Q2 2016$0.47$0.48+$0.01$0.57$927.69 million$932.00 million 5/3/2016Q1 2016$0.34$0.35+$0.01$0.33$832.03 million$847.00 million 2/4/2016Q4 2015$0.60$0.60$0.57$997.15 million$994.00 million 10/29/2015Q3 2015$0.48$0.49+$0.01$0.50$897.80 million$902.00 million 7/30/2015Q2 2015$0.43$0.43$0.45$924.98 million$920.00 million 4/30/2015Q1 2015$0.31$0.33+$0.02$0.31$840.60 million$837.00 million 2/5/2015Q4 2014$0.60$0.62+$0.02$0.72$1.03 billion$1.04 billion 10/28/2014Q3 2014$0.52$0.53+$0.01$0.48$982.10 million$963.00 million 7/29/2014Q2 2014$0.44$0.48+$0.04$0.49$994.85 million$1.01 billion 4/29/2014Q1 2014$0.32$0.34+$0.02$0.42$888.90 million$906.00 million 2/4/2014Q4 2013$0.52$0.56+$0.04$0.75$920.07 million$1.03 billion 10/29/2013Q3 2013$0.35$0.49+$0.14$0.59$918.70 million$965.00 million 7/30/2013Q2 2013$0.44$0.36($0.08)$0.47$967.90 million$960.00 million 4/30/2013Q1 2013$0.28$0.27($0.01)$0.32$893.56 million$879.00 million 2/7/2013Q4 2012$0.46$0.47+$0.01$980.57 million$969.00 million 11/1/2012Q312$0.43$0.44+$0.01$924.00 million$931.00 million8/2/2012$0.49$0.495/3/2012$0.37$0.36($0.01)2/28/2012$0.45$0.40($0.05)11/21/2011$0.43$0.55+$0.12Xylem Earnings - Frequently Asked Questions When is Xylem's earnings date? Xylem has confirmed that its next quarterly earnings data will be published on Thursday, May 4th, 2023. Learn more on XYL's earnings history. Did Xylem beat their earnings estimates last quarter? In the previous quarter, Xylem (NYSE:XYL) reported $0.92 earnings per share (EPS) to beat the analysts' consensus estimate of $0.79 by $0.13. Learn more on analysts' earnings estimate vs. XYL's actual earnings. How can I listen to Xylem's earnings conference call? The conference call for Xylem's latest earnings report can be listened to online. Listen to Conference Call How can I read Xylem's conference call transcript? The conference call transcript for Xylem's latest earnings report can be read online. Read Transcript How much revenue does Xylem generate each year? Xylem (NYSE:XYL) has a recorded annual revenue of $5.52 billion. How much profit does Xylem generate each year? Xylem (NYSE:XYL) has a recorded net income of $355 million. XYL has generated $1.96 earnings per share over the last four quarters. What is Xylem's price-to-earnings ratio? Xylem (NYSE:XYL) has a trailing price-to-earnings ratio of 50.30 and a forward price-to-earnings ratio of 30.81. The price/earnings-to-growth ratio is 2.54. What is Xylem's EPS forecast for next year? Xylem's earnings are expected to grow from $3.20 per share to $3.57 per share in the next year, which is a 11.56% increase. More Earnings Resources from MarketBeat Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: 3 Leading Dividend Stocks Expected To Grow EarningsAI Is Giving 3 Marketing & Ad Firms Revenue & Earnings BoostGeneral Mills Retreats To Buy Zone Ahead Of Earnings FedEx Is A Buy Going Into Earnings Potential Earnings Have Rated Ambrx Biopharma a Moderate BuyLemonade Earnings Gap and Crap. Here’s Why.Is Unity Software Earnings Fallout a Buying Opportunity? Upcoming Earnings: Micron Technology (3/28/2023)BlackRock (4/12/2023)Infosys (4/12/2023)Progressive (4/13/2023)Taiwan Semiconductor Manufacturing (4/13/2023)U.S. Bancorp (4/13/2023)Wells Fargo & Company (4/13/2023)Citigroup (4/14/2023)JPMorgan Chase & Co. (4/14/2023)UnitedHealth Group (4/14/2023) This page (NYSE:XYL) was last updated on 3/25/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.